Time Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how outrageous pricing and egregious profits are destroying America's healthcare and creating even deeper budget deficits. Brill spent seven months analyzing bills from hospitals, doctors, drug companies and every other player in the American healthcare ecosystem, following the money to find out exactly how and why we are overspending, where the money is going and how to get it back. What he discovered will radically change the way you think about our medical institutions. 

The American Society of Echocardiography (ASE) has joined the ABIM Foundation and 37 other specialty societies as part of Choosing Wisely, an effort to reduce inappropriate tests and procedures to improve care. This initiative aims to spark conversations about appropriate care between physicians and patients to help physicians provide the right care at the right time for the right patient.

Guerbet announced that the Medical Imaging Drugs Advisory Committee to U.S. Food and Drug Administration (FDA) has voted unanimously by votes of 17 to zero to recommend that FDA approve the New Drug Application (NDA) for Dotarem (gadoterate meglumine) for adults, and for pediatric use for children two years of age and older. The committee voted 10 to six (with one member abstaining) not to recommend at this time approval of the indication for children under two years of age.

CardioLogical Solutions is an emerging cardiovascular device company formed by the merger of Emboline and VasoStitch and its breakthrough platform of accessory devices for transcatheter aortic valve replacement (TAVR) procedures.

 

Biosense Webster showcased its portfolio of cutting edge innovative electrophysiology technologies at the 2013 Boston AF meeting.

 

 

In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD Application, available for the iPhone and iPad to ensure that 100 percent of patients screened meet the evidence-based criteria for implantation.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now